NCM
WST icon

Next Capital Management’s West Pharmaceutical WST Stock Holding History

Next Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-53
Closed -$7K – 813
2019
Q2 		$7K Buy
+53
New +$6.26K ﹤0.01% 552

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Next Capital Management's WST Position: Q3 2019 in Review

Next Capital Management sold out of West Pharmaceutical (WST) in Q3 2019, closing a stake of 53 shares — an estimated $7K sold.

Next Capital Management first reported a position in WST in Q2 2019 and held it in 1 quarter. The position peaked at $7K in Q2 2019. 406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

  • Next Capital Management reported no remaining West Pharmaceutical position as of Q3 2019 after selling out during the quarter.
  • Next Capital Management sold 53 West Pharmaceutical shares in Q3 2019, an estimated $7K.
  • Next Capital Management first reported a position in West Pharmaceutical in Q2 2019 and held it in 1 quarter.
  • Next Capital Management's West Pharmaceutical position peaked at $7K in Q2 2019.
  • 406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on Next Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.